tibolone has been researched along with Obesity in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alshahrani, MS; Baradwan, S; Ju, H; Santos, HO; Yuan, Q | 1 |
| Morin-Papunen, LC; Raudaskoski, T; Ruokonen, A; Tapanainen, JS; Vauhkonen, I | 1 |
| Aytan, H; Kelekci, S; Mollamahmutoglu, L; Oguz, S; Sargin, A; Tapisiz, OL | 1 |
| Bozkaya, H; Okumuş, B; Osmanağaoğlu, MA; Osmanağaoğlu, S; Osmanağaoğlu, T | 1 |
1 review(s) available for tibolone and Obesity
| Article | Year |
|---|---|
Does tibolone treatment have favorable effects on obesity, blood pressure, and inflammation? A meta-analysis of randomized controlled trials.
Topics: Blood Pressure; Female; Humans; Inflammation; Norpregnenes; Obesity; Randomized Controlled Trials as Topic | 2022 |
3 trial(s) available for tibolone and Obesity
| Article | Year |
|---|---|
Effects of tibolone and cyclic hormone replacement therapy on glucose metabolism in non-diabetic obese postmenopausal women: a randomized study.
Topics: Area Under Curve; Blood Glucose; Drug Therapy, Combination; Dydrogesterone; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Fatty Acids, Nonesterified; Female; Glucose; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Linear Models; Lipid Metabolism; Middle Aged; Norpregnenes; Obesity; Oxidation-Reduction; Postmenopause | 2004 |
The role of hormone replacement therapy in endometrial polyp formation.
Topics: Adult; Contraceptives, Oral, Synthetic; Double-Blind Method; Endometrium; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Hysteroscopy; Medroxyprogesterone; Menopause; Middle Aged; Norethindrone; Norpregnenes; Obesity; Polyps; Prospective Studies; Recurrence; Regression Analysis | 2005 |
Effect of different preparations of hormone therapy on lipid and glucose metabolism, coagulation factors, and bone mineral density in overweight and obese postmenopausal women.
Topics: Adult; Aged; Blood Coagulation Factors; Blood Glucose; Body Mass Index; Bone Density; Contraceptives, Oral, Synthetic; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lipids; Medroxyprogesterone; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Obesity; Overweight; Pharmaceutical Preparations; Postmenopause | 2005 |